Daré Bioscience completed a closing of its previously announced Regulation A offering of up to 4,854,000 units priced at USD 5 per unit. The company issued 43,050 investor units consisting of 43,050 shares of Series A convertible preferred stock and warrants to purchase up to 86,100 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-010594), on March 17, 2026, and is solely responsible for the information contained therein.